Deutsche Bank Ag\ Inovio Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $37,488 - $90,637	47,454 Added 31.77%	196,814 $161,000
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $75,016 - $133,007	53,203 Added 55.33%	149,360 $233,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $21,518 - $36,166	-12,963 Reduced 11.88%	96,157 $166,000
Q2 2022 Aug 11, 2022	SELL	$1.44 - $3.98 $20,458 - $56,543	-14,207 Reduced 11.52%	109,120 $189,000
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $36,189 - $63,362	-12,185 Reduced 8.99%	123,327 $443,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $33,712 - $50,399	6,756 Added 5.25%	135,512 $676,000
Q3 2021 Nov 04, 2021	SELL	$7.16 - $9.69 $97,569 - $132,045	-13,627 Reduced 9.57%	128,756 $922,000
Q2 2021 Aug 11, 2021	SELL	$6.23 - $10.03 $17,786 - $28,635	-2,855 Reduced 1.97%	142,383 $1.32 Million
Q1 2021 May 13, 2021	BUY	$8.81 - $16.96 $29,020 - $55,866	3,294 Added 2.32%	145,238 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $315,035 - $476,259	37,063 Added 35.34%	141,944 $1.26 Million
Q3 2020 Nov 12, 2020	BUY	$9.57 - $27.05 $129,080 - $364,850	13,488 Added 14.76%	104,881 $1.22 Million
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $409,364 - $1.82 Million	57,334 Added 168.34%	91,393 $2.46 Million
Q1 2020 May 14, 2020	SELL	$2.98 - $14.09 $151,711 - $717,321	-50,910 Reduced 59.92%	34,059 $254,000
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $115,928 - $218,910	58,847 Added 225.28%	84,969 $278,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $148,948 - $219,427	-72,658 Reduced 73.56%	26,122 $53,000
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $600,268 - $1.07 Million	-262,126 Reduced 72.63%	98,780 $289,000
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $214,334 - $327,277	64,172 Added 21.63%	360,906 $1.35 Million
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $1.43 Million - $2.25 Million	-368,199 Reduced 55.37%	296,734 $1.19 Million
Q3 2018 Dec 21, 2021	BUY	$3.92 - $5.58 $481,654 - $685,620	122,871 Added 22.67%	664,933 $3.7 Million
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $154,424 - $219,818	39,394 Added 7.84%	542,062 $3.01 Million
Q2 2018 Apr 21, 2020	BUY	$3.88 - $5.16 $164,597 - $218,897	42,422 Added 9.22%	502,668 $1.97 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $619,372 - $823,701	-159,632 Reduced 25.75%	460,246 $1.8 Million
Q1 2018 Oct 18, 2019	BUY	$4.05 - $5.69 $790,025 - $1.11 Million	195,068 Added 45.92%	619,878 $2.92 Million
Q1 2018 May 15, 2018	SELL	$4.05 - $5.69 $100,836 - $141,669	-24,898 Reduced 5.54%	424,810 $2 Million
Q4 2017 Feb 14, 2018	BUY	$4.13 - $6.68 $1.32 Million - $2.14 Million	320,376 Added 247.72%	449,708 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $693,219 - $823,844	129,332	129,332 $818,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account